An interventional study of Critical Time Intervention-Residential (CTI-R) and Enhanced Usual Discharge Services-Residential in Substance Use Disorders, sponsored by New York University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-01.
Sponsored by New York University · Not applicable, Interventional, and Treatment
This research uses a multi-phase approach to adapt and implement an established intervention, Critical Time Intervention, for a new population and setting among individuals with substance use who are at risk of relapse following residential substance abuse treatment. The goals of the study are to: (PHASE 1) identify challenges and strategies of community reentry among individuals in residential substance abuse treatment and their providers and social support networks (e.g., family, friends, community members); (PHASE 2) adapt CTI for individuals in residential substance abuse treatment to prepare them for discharge and transition back into the community; and (PHASE 3) conduct a pilot study to examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services.
This randomized pilot study will examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services. More specifically, 60 participants will be randomized to either CTI (n=30) or enhanced usual discharge planning services (n=30) at the time of discharge. Participants will complete a baseline interview (prior to randomization) and 3-, 6-, 9- and 12-month follow-up assessments post-discharge.
2,181 studies on the registry are indexed under Substance-Related Disorders; 399 are open to participants now.
This study's enrollment of 60 is below the median of 108 across 1,770 interventional studies indexed under Substance-Related Disorders.
Browse Substance-Related Disorders studies →New York University is the lead sponsor of 123 studies on the registry; 32 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Individuals that do not meet the aforementioned inclusion criteria will be excluded from the study.More specifically, the following categories will be excluded:
CTI-R is a 9-month, assertive outreach and linkage program.
Behavioral: Critical Time Intervention-Residential (CTI-R) · Behavioral: Enhanced Usual Discharge Services-Residential
The enhanced usual discharge condition includes usual discharge services plus enhanced transition services.
Behavioral: Enhanced Usual Discharge Services-Residential
CTI-R is a 9-month, time-limited intervention that aims to produce an enduring impact by effectively linking individuals to both professional services (substance abuse and health and mental health providers) and social supports (e.g., family and friends) and by providing emotional and practical support. Participants in the CTI-R condition will also receive usual discharge services from the residential substance abuse treatment program.
The enhanced usual discharge condition encompasses the regular discharge services offered at the residential treatment program plus enhanced transition services.
Enrollment
Proportion of participants enrolled in the study as measured by the research records
Time frame: Baseline
Change in retention
Proportion of participants completed the study as measured by the research records
Time frame: 3, 6, 9, and 12 months
Short-term Relapse
Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index
Time frame: 3 months
Use of aftercare services
Proportion of participants who were linked to aftercare services (i.e. substance use treatment) at the time of discharge as measured by the Treatment Service Review (TSR)
Time frame: 3 months
Housing
Proportion of participants housed at the time of discharge
Time frame: 3 months
Short-term Social Support
Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey
Time frame: 3 months
Short-term Self-Efficacy
Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."
Time frame: 3 months
Short-term Mental Health
Level of mental health severity as measured by the Brief Symptom Inventory
Time frame: 3 months
Change in Relapse
Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index
Time frame: 3, 6, and 9 months
Long-term Relapse
Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index
Time frame: 12 months
Change in Social Support
Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey
Time frame: 3, 6, and 9 months
Long-term Social Support
Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey
Time frame: 12 months
Change in Self-Efficacy
Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."
Time frame: 3, 6, and 9 months
Long-term Self-Efficacy
Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."
Time frame: 12 months
Change in Mental Health
Level of mental health severity as measured by the Brief Symptom Inventory
Time frame: 3, 6, and 9 months
Long-term Mental Health
Level of mental health severity as measured by the Brief Symptom Inventory
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
Ran from May 2017 to primary completion in May 2020, 36 months.
Of 812 non-industry interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 36 months is close to that.
Counting every sponsor, half of 855 studies reached it within 32 months; a quarter within 16 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.